222: COSENTYX® (secukinumab) Cases: An Interactive Game-Based Challenge

Industry Presenter(s)

• AC

  Andre Cartwright

  Associate Director, Thought Leader Liaison
  Novartis
  Atlanta, Georgia, United States

  Disclosure information not submitted.
• LG

  Linda Grinnell-Merrick, NP, MS - BC

  Medical Director, Rheumatology
  Novartis
  Macedon, New York, United States

  Disclosure information not submitted.

• COSENTYX Cases: An Interactive Game-Based Challenge is an interactive game-based challenge designed to test the players’ knowledge in a competitive but friendly environment
• This program includes 3 rounds, each focused on a different disease area
• In each round, a patient scenario is followed by a series of questions that players are invited to respond to using the device provided. Once all players have selected a response, the correct answer will be revealed and the moderator will discuss rationale for the answer and review key points of supporting information

Developed & offered by Novartis Pharmaceuticals Corporation.